Skip to main content
Kimberly (Hawthorne) Goodspeed, MD, Pediatrics, Dallas, TX, Children's Medical Center Dallas

KimberlyDianne(Hawthorne)GoodspeedMD

Pediatrics Dallas, TX

Neurodevelopmental Disabilities

Physician

Overview of Dr. Goodspeed

Dr. Kimberly Goodspeed is a pediatrician in Dallas, TX and is affiliated with multiple hospitals in the area, including Children's Medical Center Dallas and University of Texas Southwestern Medical Center. She received her medical degree from McGovern Medical School at UTHealth and has been in practice 5 years. She is one of 517 doctors at Children's Medical Center Dallas and one of 267 doctors at University of Texas Southwestern Medical Center who specialize in Pediatrics. She has more than 10 publications and over 400 citings.

Education & Training

  • University of Texas Southwestern Medical Center
    University of Texas Southwestern Medical CenterFellowship, Neurodevelopmental Disabilities, 2014 - 2018
  • University of Texas Southwestern Medical Center
    University of Texas Southwestern Medical CenterResidency, Pediatrics, 2012 - 2015
  • McGovern Medical School at UTHealth
    McGovern Medical School at UTHealthClass of 2012

Certifications & Licensure

  • TX State Medical License
    TX State Medical License 2017 - 2024
  • American Board of Pediatrics Pediatrics
  • American Board of Psychiatry and Neurology Neurology with Special Qualification in Child Neurology
  • American Board of Psychiatry and Neurology Neurodevelopmental Disabilities

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Pitt-Hopkins Syndrome: A Unique Case Study  
    Veronica Bordes Edgar, Kimberly Goodspeed, Journal of the International Neuropsychological Society

Press Mentions

  • Repurposing Approved Drugs as Inhibitors of K v 7.1 and Na v 1.8 to Treat Pitt Hopkins Syndrome
    Repurposing Approved Drugs as Inhibitors of K v 7.1 and Na v 1.8 to Treat Pitt Hopkins SyndromeJuly 22nd, 2020
  • Bringing Everyone to the Table – Findings from the 2018 Phelan-McDermid Syndrome Foundation International Conference
    Bringing Everyone to the Table – Findings from the 2018 Phelan-McDermid Syndrome Foundation International ConferenceJune 16th, 2020
  • Neurogene Initiates Natural History Study of Aspartylglucosaminuria (AGU)
    Neurogene Initiates Natural History Study of Aspartylglucosaminuria (AGU)April 23rd, 2019

Hospital Affiliations